83937 Assay of osteocalcin
Also known as: osteocalcin assay, bone formation marker
Quantitative measurement of osteocalcin in serum using immunoassay methodology.
In Plain Language
bone building protein test
Clinical Context
Marker of bone osteoblast activity and bone formation used in metabolic bone disease evaluation. Elevated in hyperparathyroidism and Paget disease.
RVU Information
CPT 83937 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 83937?
CPT 83937 (Assay of osteocalcin) is a Pathology & Lab code. Quantitative measurement of osteocalcin in serum using immunoassay methodology.
Who uses CPT code 83937?
CPT 83937 is used by Pathology, Endocrinology, Orthopedics. Marker of bone osteoblast activity and bone formation used in metabolic bone disease evaluation. Elevated in hyperparathyroidism and Paget disease.
When is CPT 83937 used?
Marker of bone osteoblast activity and bone formation used in metabolic bone disease evaluation. Elevated in hyperparathyroidism and Paget disease.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.